Nonclinical Evaluation Report, FOI 2839 Document 6, January 2021 and comment

See 58 page report:

See also: PFIZER CONFIDENTIAL:- RISK MANAGEMENT PLAN – AUSTRALIA-SPECIFIC ANNEX

See also: Advisory Committee on Vaccines, Meeting 18, Minutes on Item 2.1

BNT162b2 [mRNA] COVID-19 vaccine

See comment video on the first document only, as they may not have been aware of the other two listed above:

Source

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes